February 21st 2025, 10:00pm
An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.
February 21st 2025, 8:00pm
Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.
February 21st 2025, 6:00pm
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
February 21st 2025, 5:00pm
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025, 4:00pm
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
February 21st 2025, 2:00pm
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety and antileukemic activity.
February 20th 2025, 10:00pm
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
February 20th 2025, 8:05pm
In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and safe.
February 20th 2025, 6:00pm
My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.
February 20th 2025, 5:00pm
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
The Importance of Genetic Testing in Metastatic Colorectal Cancer
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
Cancer is Hard Enough Without Infections
How Patients With Cancer Can Avoid Counterfeit Therapeutics Online